Statistics from Altmetric.com
Between 2008 and 2017, health-related legal demands have increased 130% in Brazil.1 In 2016, the 10 most expensive drugs that were legally required comprised 91% of the resources guaranteed for the acquisition of technologies by the Brazilian government.1 These drugs were intended for 1213 users of Brazilian Public Health System (SUS), which covers 140 million Brazilians. In this scenario, it has been necessary to adopt strategies to enhance the judicial process, ensuring evidence-informed judicial decisions.
Through a broad project of the Brazilian Ministry of Health, formally named PROADI-SUS, a collaborative agreement has been established between Hospital Sírio-Libanês and the National Council of Justice …
CAP, DAV, RR and LFLR are joint senior authors.
Contributors Conception and design: CAP, CMT, DAV, LFLR. Data collection: AMdQ, ATF, ADZ, FdAR. Manuscript draft: CAP, FdAR, AMdQ, ADZ. Content revisor: CAP, DAV, CMT, RR, LFLR. Final approval: all authors.
Funding This study was supported by the Brazilian Ministry of Health through the Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde (PROADI-SUS Program), led by Hospital Sírio- Libanês, São Paulo, Brazil.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.